-+ 0.00%
-+ 0.00%
-+ 0.00%

HUTCHMED (CHINA) - REITERATES FY2026 GUIDANCE FOR ONCOLOGY/IMMUNOLOGY REVENUE OF $330-$450 MLN

Reuters·07/30/2026 11:00:02

Please log in to view news